Administering antihypertensive drugs after acute ischemic stroke: timing is everything.
Semplicini
Andrea
A
Department of Clinical and Experimental Medicine, University of Padua Medical School, Padua, Italy.
Calò
Lorenzo
L
D000208:Acute Disease; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply / Q000503:physiopathology; D002545:Brain Ischemia / Q000150:complications* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology; D006706:Homeostasis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007741:Labetalol / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D020521:Stroke / Q000150:complications*; D013997:Time Factors
D000959:Antihypertensive Agents; D009599:Nitroprusside; D007741:Labetalol
Arch Intern Med. 2003 Jan 27;163(2):211-6
12546612
Stroke. 2002 May;33(5):1315-20
11988609
Stroke. 2004 Feb;35(2):520-6
14726553
Lancet Neurol. 2003 Nov;2(11):698-701
14572738